ALLO stock · UBER stock

ALLO vs UBER

Allogene Therapeutics Inc (ALLO) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.

Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.

Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.

Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.

Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.

ALLO currently screens at market cap $258.1M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.

Not investment advice. Open the ALLO and UBER stock pages for the full models.

Not investment advice.

Popular Stock Comparisons